Acute pancreatitis may progress to chronic with sustained heavy alcohol use

by Lori SolomonMany patients with recurrent acute pancreatitis (RAP) and acute pancreatitis (AP) have high lifetime cumulative drinking and heavy daily alcohol use, suggesting disease progression towa

Updated on: June 12,2024

Acute pancreatitis may progress to chronic with sustained heavy alcohol use

by Lori SolomonMany patients with recurrent acute pancreatitis (RAP) and acute pancreatitis (AP) have high lifetime cumulative drinking and heavy daily alcohol use, suggesting disease progression towa

Updated on:June 12,2024

Diabetes and Liver Cancer: What Is the Relationship?

Diabetes and Liver Cancer: What Is the Relationship?ByJames Myhre & Dennis Sifris, MDPublished on November 17, 2022Medically reviewed byIsabel Casimiro, MD, PhDDiabetes&nbs

Updated on: July 01,2024

Diabetes and Liver Cancer: What Is the Relationship?

Diabetes and Liver Cancer: What Is the Relationship?ByJames Myhre & Dennis Sifris, MDPublished on November 17, 2022Medically reviewed byIsabel Casimiro, MD, PhDDiabetes&nbs

Updated on:July 01,2024

What Is Fatty Liver Disease?

What Is Fatty Liver Disease?ByAnnie KayUpdated on April 20, 2024Medically reviewed byRobert Burakoff, MDFatty liver is also known as hepatic steatosis. It happens when fat buil

Updated on: July 01,2024

What Is Fatty Liver Disease?

What Is Fatty Liver Disease?ByAnnie KayUpdated on April 20, 2024Medically reviewed byRobert Burakoff, MDFatty liver is also known as hepatic steatosis. It happens when fat buil

Updated on:July 01,2024

Scientists find omega-3 lysolipids may prevent fatty liver disease

by Duke-NUS Medical SchoolDetection of the lysolipid transporter Mfsd2a in hepatocytes, stained green, in proximity to a bile duct, stained magenta. Credit: Chin Cheen FeiLong-running research by

Updated on: June 03,2024

Scientists find omega-3 lysolipids may prevent fatty liver disease

by Duke-NUS Medical SchoolDetection of the lysolipid transporter Mfsd2a in hepatocytes, stained green, in proximity to a bile duct, stained magenta. Credit: Chin Cheen FeiLong-running research by

Updated on:June 03,2024

Ultrasonography of hepatocellular carcinoma: From diagnosis to prognosis

by Xia & He Publishing Inc.Hepatocellular carcinoma (HCC) is a prominent contributor to cancer-related mortality worldwide. Early detection and diagnosis of liver cancer can significantly improve

Updated on: July 17,2024

Ultrasonography of hepatocellular carcinoma: From diagnosis to prognosis

by Xia & He Publishing Inc.Hepatocellular carcinoma (HCC) is a prominent contributor to cancer-related mortality worldwide. Early detection and diagnosis of liver cancer can significantly improve

Updated on:July 17,2024

Exploring the pathogenesis of autoimmune liver diseases from the heterogeneity of target cells

by Xia & He Publishing Inc.Hepatoblasts differentiate into hepatocytes, large and small cholangiocytes. CK8, CK18, and CK19 are expressed in hepatoblasts. CK8 and CK18 are expressed in hepatocytes

Updated on: July 19,2024

Exploring the pathogenesis of autoimmune liver diseases from the heterogeneity of target cells

by Xia & He Publishing Inc.Hepatoblasts differentiate into hepatocytes, large and small cholangiocytes. CK8, CK18, and CK19 are expressed in hepatoblasts. CK8 and CK18 are expressed in hepatocytes

Updated on:July 19,2024

Protein controlling magnesium identified as therapeutic target for non-alcoholic fatty liver disease

by New York UniversityThe study identified the CNNM4 protein as a key regulator of magnesium (Mg) in the liver and potential therapeutic target for non-alcoholic fatty liver disease (NASH). Credi

Updated on: June 28,2024

Protein controlling magnesium identified as therapeutic target for non-alcoholic fatty liver disease

by New York UniversityThe study identified the CNNM4 protein as a key regulator of magnesium (Mg) in the liver and potential therapeutic target for non-alcoholic fatty liver disease (NASH). Credi

Updated on:June 28,2024

Metabolic reprogramming and HIF-1α signaling in liver fibrosis and pathological angiogenesis

Updated on: September 21,2024

Metabolic reprogramming and HIF-1α signaling in liver fibrosis and pathological angiogenesis

Updated on:September 21,2024

Study provides basis for personalized hepatitis C aftercare

by Medical University of ViennaCredit: AI-generated imageEven after chronic hepatitis C has been cured, portal hypertension remains the major factor driving the development of complications in ad

Updated on: April 03,2024

Study provides basis for personalized hepatitis C aftercare

by Medical University of ViennaCredit: AI-generated imageEven after chronic hepatitis C has been cured, portal hypertension remains the major factor driving the development of complications in ad

Updated on:April 03,2024

Causes and Risk Factors of Liver Disease

Causes and Risk Factors of Liver DiseaseByKelly BurchUpdated on October 17, 2022Medically reviewed byRobert Burakoff, MDYourliveris one of the largest organs in you

Updated on: July 01,2024

Causes and Risk Factors of Liver Disease

Causes and Risk Factors of Liver DiseaseByKelly BurchUpdated on October 17, 2022Medically reviewed byRobert Burakoff, MDYourliveris one of the largest organs in you

Updated on:July 01,2024

Norovirus study shows how bile acids in breast milk affect newborn gut health

by Jiayu Liang,University of FloridaGraphical abstract. Credit:Cell Host & Microbe(2024). DOI: 10.1016/j.chom.2024.08.003A University of Florida researcher has compiled the first

Updated on: September 11,2024

Norovirus study shows how bile acids in breast milk affect newborn gut health

by Jiayu Liang,University of FloridaGraphical abstract. Credit:Cell Host & Microbe(2024). DOI: 10.1016/j.chom.2024.08.003A University of Florida researcher has compiled the first

Updated on:September 11,2024

Novel pathway could lead to potential treatment for metabolic liver disease

by Hayley Mignacca,University of Massachusetts Medical SchoolLyz-IFNγR2−/−mice are rescued from fatty liver progression to MASH. Credit:Nature Communications(2024). DOI: 10.103

Updated on: September 02,2024

Novel pathway could lead to potential treatment for metabolic liver disease

by Hayley Mignacca,University of Massachusetts Medical SchoolLyz-IFNγR2−/−mice are rescued from fatty liver progression to MASH. Credit:Nature Communications(2024). DOI: 10.103

Updated on:September 02,2024